These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 2117919)

  • 21. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol-deprivation increases mono-unsaturated very long-chain fatty acids in skin fibroblasts from patients with X-linked adrenoleukodystrophy.
    Engelen M; Ofman R; Mooijer PA; Poll-The BT; Wanders RJ; Kemp S
    Biochim Biophys Acta; 2008 Mar; 1781(3):105-11. PubMed ID: 18206987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisomal beta-oxidation enzyme proteins in adrenoleukodystrophy: distinction between X-linked adrenoleukodystrophy and neonatal adrenoleukodystrophy.
    Chen WW; Watkins PA; Osumi T; Hashimoto T; Moser HW
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1425-8. PubMed ID: 3469675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the testosterone metabolite dihydrotestosterone and 5 alpha-androstan-3 alpha,17 beta-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts.
    Petroni A; Blasevich M; Uziel G
    Life Sci; 2003 Aug; 73(12):1567-75. PubMed ID: 12865096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM
    Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very long chain fatty acid beta-oxidation by subcellular fractions of normal and Zellweger syndrome skin fibroblasts.
    Singh H; Derwas N; Poulos A
    Arch Biochem Biophys; 1987 Sep; 257(2):302-14. PubMed ID: 3662528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
    Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
    J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baicalein 5,6,7-trimethyl ether, a flavonoid derivative, stimulates fatty acid beta-oxidation in skin fibroblasts of X-linked adrenoleukodystrophy.
    Morita M; Takahashi I; Kanai M; Okafuji F; Iwashima M; Hayashi T; Watanabe S; Hamazaki T; Shimozawa N; Suzuki Y; Furuya H; Yamada T; Imanaka T
    FEBS Lett; 2005 Jan; 579(2):409-14. PubMed ID: 15642351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids.
    Rizzo WB; Watkins PA; Phillips MW; Cranin D; Campbell B; Avigan J
    Neurology; 1986 Mar; 36(3):357-61. PubMed ID: 3951702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
    Khan M; Pahan K; Singh AK; Singh I
    J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; van den Bosch H; Schram AW; Tager JM
    Biochem Biophys Res Commun; 1988 Jun; 153(2):618-24. PubMed ID: 3382393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
    Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
    J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of exogenous monounsaturated fatty acids on fatty acid metabolism in cultured skin fibroblasts from adrenoleukodystrophy patients.
    Wilson R; Tocher DR; Sargent JR
    J Neurol Sci; 1992 Jun; 109(2):207-14. PubMed ID: 1634904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Straight-chain acyl-CoA oxidase knockout mouse accumulates extremely long chain fatty acids from alpha-linolenic acid: evidence for runaway carousel-type enzyme kinetics in peroxisomal beta-oxidation diseases.
    Infante JP; Tschanz CL; Shaw N; Michaud AL; Lawrence P; Brenna JT
    Mol Genet Metab; 2002 Feb; 75(2):108-19. PubMed ID: 11855929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological significance of fatty acid elongation system in adrenoleukodystrophy.
    Koike R; Tsuji S; Ohno T; Suzuki Y; Orii T; Miyatake T
    J Neurol Sci; 1991 Jun; 103(2):188-94. PubMed ID: 1880537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD).
    Tsuji S; Ohno T; Miyatake T; Suzuki A; Yamakawa T
    J Biochem; 1984 Oct; 96(4):1241-7. PubMed ID: 6520122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of a novel arachidonic acid metabolite in peroxisomes.
    Gordon JA; Heller SK; Rhead WJ; Watkins PA; Spector AA
    Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):77-81. PubMed ID: 7540307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation.
    Inoue K; Suzuki Y; Yajima S; Shimozawa N; Tomatsu S; Orii T; Kondo N
    Clin Genet; 1996 Nov; 50(5):348-52. PubMed ID: 9007322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.